Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Beckley Foundation | Researchclopedia

Back to institutions

Beckley Foundation

Oxfordnonprofit

118

Works

14,361

Citations

49

h-index

Top Research Topics

Psychedelics and Drug Studies Neurotransmitter Receptor Influence on Behavior Chemical synthesis and alkaloids

Top Researchers

Claire T. Roberts Beckley Foundation

477 works13,482 citationsh-index: 62

Recent Research

Intranasal 5-MeO-DMT Concomitant with SSRI for Treatment-Resistant Depression: A Proof-of-Concept Trial

Mathieu Seynaeve,Fiona Dunbar,et al.

20260 citations

Biochemical Analysis and Sensing Techniques

Cannabis and Cannabinoid Research

Complementary and Alternative Medicine Studies

Olfactory and Sensory Function Studies

Pain Management and Placebo Effect

Paranormal Experiences and Beliefs

Forensic Toxicology and Drug Analysis

Tryptophan and brain disorders

Functional Brain Connectivity Studies

Amanda Feilding Beckley Foundation

93 works13,383 citationsh-index: 44

Paul A. Gore Xavier University

65 works5,702 citationsh-index: 22

113 works5,221 citationsh-index: 34

Valérie Bonnelle Citrix (Switzerland)

32 works4,106 citationsh-index: 17

Chandni Hindocha University College London

95 works3,760 citationsh-index: 32

A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy- <i>N,N</i> -dimethyltryptamine) in patients with treatment-resistant depression

Claire T. Roberts,Mathieu Seynaeve,et al.

20260 citations

Psychedelic Therapy: A Primer for Primary Care Clinicians—5-Methoxy-N,N-Dimethyltryptamine

Burton J. Tabaac,Kenneth Shinozuka,et al.

20260 citations

The efficacy of intranasal BPL-003 (5-methoxy-N,N-dimethyltryptamine) on anhedonia in patients with treatment resistant depression: a phase 2a open label study

C. Hindocha,S. McGuigan,et al.

20261 citations

5‐Methoxy‐ <i>N</i> , <i>N</i> ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

John Marsden,Michael Kelleher,et al.

20251 citations

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults

Anna O. Ermakova,Fiona Dunbar,et al.

20253 citations